Clinical Trial

Long-term Follow-up of Subjects Treated With CAR T Cells

Recruiting
View on ClinicalTrials.gov →
Summary
This is a single site, non-randomized, open-label, long-term safety and efficacy follow-up study for Phase 1 studies that evaluate the safety and efficacy of CAR T cells: NCT05660369 (DF/HCC# 22-175) and NCT06026319 (DF/HCC# 23-474).
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2021-08-23; most recent amendment 2026-03-13.
Status change: Not Yet Recruiting → Recruiting 2024-09-18
Trial Details
NCT Number NCT05024175
Lead Sponsor Marcela V. Maus, M.D.,Ph.D.
Conditions Long Term Adverse Effects, CAR-T, Duty to Follow Up, Adult, Progression-Free Survival, Disease-Free Survival, Overall Survival
Enrollment 45 participants
Start Date 2023-08-07
Primary Completion 2038-08-01 (estimated)
Study Completion 2039-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-16